Terms: = Prostate cancer AND EPS15, AF-1P, 2060, ENSG00000085832, P42566, MLLT5, AF1P AND Diagnosis
3 results:
1. Regional differences in penile cancer patient characteristics and treatment rates across the United States.
Scheipner L; Cano Garcia C; Barletta F; Incesu RB; Morra S; Baudo A; Assad A; Tian Z; Saad F; Shariat SF; Chun FKH; Briganti A; Tilki D; Longo N; Carmignani L; Leitsmann M; Ahyai S; Karakiewicz PI
Cancer Epidemiol; 2023 Oct; 86():102424. PubMed ID: 37506474
[TBL] [Abstract] [Full Text] [Related]
2. prostate cancer-specific mortality burden by risk group among men with localized disease: Implications for research and clinical trial priorities.
Dee EC; Nezolosky MD; Chipidza FE; Arega MA; Butler SS; Sha ST; Mahal BA; Nguyen PL; Yang DD; Muralidhar V
Prostate; 2020 Sep; 80(13):1128-1133. PubMed ID: 32659024
[TBL] [Abstract] [Full Text] [Related]
3. [The clinical value of PSA and ECT in diagnosis of prostate cancer bone metastasis].
Ma HQ; Ge JP; Wei W; Gao JP
Zhonghua Nan Ke Xue; 2002; 8(4):289-91. PubMed ID: 12491698
[TBL] [Abstract] [Full Text] [Related]
